Heparin surface treatment does not impair gas and heat transfer of an extracorporeal circuit

Abstract

Surface treatment of a cardiopulmonary bypass circuit with heparin improves its haemocompatibility. However, potential side effects of this layer of heparin are impairment of O₂ transfer and CO₂ transfer in the oxygenator and heat transfer in the heat exchanger.

Therefore we studied these side effects during extracorporeal circulation with moderate hypothermia in 30 patients who underwent elective coronary artery bypass grafting surgery. All patients were heparinized systemically. In 15 patients (Duraflo II-group) we used an extracorporeal circuit (including a Bentley Bos-CM50 membrane oxygenator) which was treated with heparin. The results of this group were compared with those obtained from another group of 15 patients (control-group), who were operated upon with an identical extracorporeal circuit but without heparin surface treatment.

We found no significant differences between the two groups in O₂ transfer, CO₂ transfer or heat transfer during normothermia or hypothermia.

We concluded that neither O₂ transfer and CO₂ transfer of the oxygenator nor heat transfer of the heat exchanger were impaired by Duraflo II heparin surface treatment during clinical cardiopulmonary bypass with moderate hypothermia.

Get full access to this article

View all access options for this article.

References

Palatianos GM , Dewanjee MK , Kapadvanjwala M. , Novak S. , Sfakianakis GN , Kaiser GA Cardiopulmonary bypass with a surface-heparinized extracorporeal perfusion system. ASAIO Trans 1990; 36: M476—79.

Tong SD , Rolfs MR , Hsu LC Evaluation of Duraflo II heparin immobilized cardiopulmonary bypass circuits . ASAIO Trans 1990; 36: M654—56.

von Segesser LK , Turina M. Cardiopulmonary bypass without systemic heparinization. Performance of heparin-coated oxygenators in comparison with classic membrane and bubble oxygenators. J Thorac Cardiovasc Surg 1989; 98: 386-96.

Videm V. , Nilsson L. , Venge P. , Svennevig JL Reduced granulocyte activation with a heparin-coated device in an in vitro model of cardiopulmonary bypass. Artificial Organs 1991; 15: 90-95.

Gu YJ , van Oeveren W. , van der Kamp Kwhj , Akkerman C. , Boonstra PW , Wildevuur ChRH. Heparin coating of extracorporeal circuits reduces thrombin formation in patients undergoing cardiopulmonary bypass. Perfusion 1991; 6: 221-25.

van Oeveren W. , Kazatchkine MD , Descamps-Latscha B. et al. Deleterious effects of cardiopulmonary bypass. A prospective study of bubble versus membrane oxygenation . J Thorac Cardiovasc Surg 1985 ; 89: 888-99.

Kirklin JK , Westaby S. , Blackstone EH , Kirklin JW , Chenoweth DE , Pacifico AD Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg 1983; 86: 845-57.

Westaby S. Organ dysfunction after cardiopulmonary bypass. A systemic inflammatory reaction initiated by the extra corporeal circuit. Intensive Care Med 1987; 13: 89-95.